Key points are not available for this paper at this time.
Anti-proliferative activity of BR-cpd7 and BGJ398 in multiple human cancer cell lines. Human cancer cells were subjected to different concentrations of BR-cpd7 or BGJ398, and IC50 at 4 or 5 days was calculated (n=3 replicates).
Kong et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: